Stent showdown: which heart device heals faster?

NCT ID NCT02253108

Ongoing Disease control Sponsor: Aarhus University Hospital Skejby Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two types of drug-coated stents (SYNERGY and BioMatrix NeoFlex) in 160 patients with coronary artery disease. Researchers use a special camera to check how well the stents heal inside the artery at 1 and 3 months after placement. The goal is to see which stent leads to better vessel healing.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: drug-eluting stent (device)
What this could lead to: If successful, this could show which stent helps blood vessels heal faster after heart procedures, potentially improving long-term outcomes.
What could go wrong: This is a small, early-phase study (160 participants) looking at healing markers, not long-term health benefits. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANGINA PECTORIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Angina Pectoris coronary artery disorder intermediate coronary syndrome myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANGINA PECTORIS CORONARY ARTERY DISEASE MYOCARDIAL INFARCTION

Contacts and locations

Locations

Aarhus University Hospital, Skejby

Aarhus, 8200, Denmark
Odense University Hospital

Odense, 5000, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.